To prevent A/H1N1 must use the same steps as that for normal seasonal influenza (World Health Organization recommendations)
- Cover nose and mouth with a tissue when you cough or sneeze. After using a towel throw in the trash.
- Wash your hands often with soap and water, especially after you’ve sneezed or coughed.
- Will be effective as the use of alcohol hand washing.
- Avoid close contact with sick people.
- Avoid touching your eyes, nose and mouth.
- Avoid hugs, kisses and handshakes.
- If you are sick, stay home and limit contact with other people, so as not to infect them, keep a minimum distance of 1 meter from the surrounding
- When flu symptoms seek immediate medical help.
“Scheme of treatment and prevention of influenza caused by virus type A/H1N1,
adult
1. Nonspecific prevention of influenza in adults.
Kagotsel – scheme 2 days on 2 tables. per day, 5 days break and another 2 days to 2 tables. per day (daily dose 24 mg) .*
or
Arbidol – direct contact with sick flu or SARS – 200 mg per day for 10-14 days *
during epidemics of influenza and other acute respiratory viral infection, to prevent
exacerbations of chronic bronchitis, recurrent herpes infection –
200 mg twice a week for 3 weeks .*
or
Interferon alpha-2b in combination with interferon gamma – 1 times per day, respectively, ME 50000 and 100000ME a day for 10 days *
* Note – except for pregnant women
1.2. For pregnant women (from the 14th week of pregnancy) can be used with interferon alfa-2b in suppozitorijah 150000ME 2 times a day (daily dose 300000ME) within 5 days.
2. Treatment of adult patients with milder forms of influenza caused by virus type A/H1N1.
2.1. Arbidol – 4 times a day, 200 mg every 6 hours (daily dose 800 mg) for 7-10 days *.
or
Interferon alpha-2b (50,000 IU per vial) in combination with interferon gamma (100000 IU in vial) – 2-6 times per day (daily dose 50 000 IU and 100 000 IU, respectively) every other day for 10 days, after a break one week repeated the same pattern *
* Note – except for pregnant women
2.2. For the treatment of pregnant women (from the 14th week of pregnancy) can be used with interferon alfa-2b in suppozitorijah – by 500000 IU 2 times a day (daily dose 1000000ME) within 5 days.
2.3. Symptomatic treatment (analgesics, the means used to treat allergic reactions, vitamins) – on the testimony
3. Treatment of adult patients with moderate forms of influenza caused by virus type A/H1N1
3.1. Kagotsel in combination with Arbidol *:
kagotsel – on the first day on the 2 tables. 3 times a day (daily dose 72 mg),
next 3 days to 1 table. 3 times a day (daily dose 36 mg);
arbidol – 4 times a day, 200 mg every 6 hours (daily dose 800 mg) in
7-10 days.
or
Interferon alpha-2b (50,000 IU per vial) in combination with interferon gamma (50000 IU per vial) – 2-6 times per day (daily dose 50 000ME and 100-000ME, respectively) every other day for 10 days, after a break of one week repeats the same pattern *
or
Ingavirin – daily dose of 90 mg 1 time a day for 5 days (including the appointment of the drug in the first 2 days of onset) *
or
Oseltamivir – 75 mg twice a day (daily dose 150 mg) for 5 days (including the appointment of the drug in the first 2-3 days of onset) *
* Note – except for pregnant women
3.2. For the treatment of pregnant women (from the 14th week of pregnancy) can be used with interferon alfa-2b in suppozitorijah 500000ME 2 times a day (daily dose-1000000ME) within 5 days. Then, maintenance therapy for 150000ME 2 times a day (daily dose of 300000ME) to 2 times a week for 3 weeks.
3.3. Symptomatic treatment (antibacterial and antifungal, analgesics, nonsteroidal anti-inflammatory drugs, the means used to treat allergic reactions, hormones, and tools that affect the endocrine system, means of affecting the respiratory, solutions, electrolytes, acid balance correction tools, power tools, vitamins and other means) – on the testimony
4. Treatment of adult patients with severe forms of influenza caused by virus type AH1N1.
4.1. Kagotsel in combination with Arbidol *:
kagotsel – on the first day on the 2 tables. 3 times a day (daily dose 72 mg),
next 3 days to 1 table. 3 times a day (daily dose 36 mg);
arbidol – 4 times a day, 200 mg every 6 hours (daily dose 800 mg) in
7-10 days.
or
Interferon alpha-2b (50,000 IU per vial) in combination with interferon gamma (100000 IU in vial) – 2-6 times per day (daily dose 50 000ME and 100-000ME, respectively) every other day for 10 days, after a break of one week repeats the same pattern *
or
Interferon gamma – 2-6 times per day (daily dose of 100,000 IU) within 15 days *
or
Ingavirin – daily dose of 90 mg 1 time a day for 5 days (including the appointment of the drug in the first 2 days of onset) *
or
Oseltamivir – 75 mg twice a day daily dose of 150 mg () within 5 days (taking into account the effectiveness of the drug in the first 3 days of onset) *
* Note – except for pregnant women
4.2. For the treatment of pregnant women (from the 14th week of pregnancy) can be used with interferon alfa-2b in suppozitorijah 500000ME 2 times a day (daily dose-1000000ME) within 10 days. Then, maintenance therapy for 150000ME 2 times a day (daily dose 300000ME) to 2 times a week for 3 weeks.
4.3. Symptomatic treatment (antibacterials, analgesics, nonsteroidal anti-inflammatory drugs, muscle relaxants, the means used to treat allergic reactions, means that affect the blood, hormones and tools that affect the endocrine system, means of influencing the cardiovascular system, solutions, electrolytes, means of correcting the acid balance, money supply, means of affecting the respiratory system, respiratory support, vitamins and other means) – if indicated.
4.4. Organization of treatment of complications – see note.
Interim guidelines
“Scheme of treatment and prevention of influenza caused by virus type A/H1N1,
children ”
1. Nonspecific prevention of influenza in children (under the threat of contracting influenza and in the foci).
Arbidol - for children aged 3-6 years 50 mg daily, 2 times for 7 days, children older than 7 years – 100 -200 mg per day, 2 times for 7 days.
or
Kagotsel - children from 7 to 12 years to 24 mg per day, 2 times for 7 days.
or
Oseltamivir (Powder for suspension for oral administration or capsules):
children from 1 to 8 years – with a weight of less than 15 kg to 30 mg, 15 to 23 kg of 45 mg, 23 to 40 kg to 60 mg over 40 kg – 75 mg 1 time a day for 5 days ;
children over 12 years – 75 mg 1 time a day for 10 days after contact with an infected person, no later than the first two days after exposure, during the influenza epidemic within 6 weeks.
Interferon gamma in combination with interferon alfa 2b (liofilizat for solution for intranasal administration, the contents of the vial or ampoule is dissolved in 5 ml of water for injections):
Interferon gamma – used in complex therapy from 0 to 18 years, 2-3 drops in each nasal passage for 30 minutes before breakfast, every other day for 10 dney.Pri necessary preventive courses povtoryayut.Pri single contact, only one burial.
Interferon alfa 2b – is used in complex therapy in contact with the patient and / or / with supercooling in accordance with the dosage of age: infants and children under 1 year (single dose of 1000 IU), 1 drop; children from 1 year to 14 years - (a single dose of 2000 IU) and 2 drops – 2 times a day for 5-7 days. If necessary preventive repeat courses. For a single contact, only one zakapyvaniya.Pri seasonal increase in incidence according to age dose in the morning after 1-2 days.
Interferon alpha-2b (suppository) (used in complex therapy) – for children under 3 years 150000ME 2 times a day every other day for 10 -14 days for children from 3 to 6 years 500000ME 2 times a day for 10 days - every other day.
2. Treatment of children with milder forms of influenza caused by virus type A H1N1.
2.1. Arbidol - children older than 7 years, the daily dose of 300 mg (100 mg 3 times daily) for 3 days
or
Oseltamivir (Powder for suspension for oral administration or capsules) not later than two days from the time of symptoms:
children from 1 to 8 years – with a weight of less than 15 kg to 30 mg, 15 to 23 kg of 45 mg, 23 to 40 kg to 60 mg over 40 kg, 75 mg 2 times a day for 5 days;
children over 12 years – 75 mg 2 times a day for 5 days. Increasing the dose of 150 mg per day does not lead to greater effect.
Interferon gamma in combination with interferon alfa 2b (liofilizat for solution for intranasal administration, the contents of the vial or ampoule is dissolved in 5 ml of water for injection):
Interferon gamma – used in complex therapy at the first signs of the disease to children from 0 to 18 years to 2 drops in each nasal passage, 5 times a day for 5-7 days;
Interferon alfa 2b – is used in complex therapy at the first signs of the disease:
infants and children under 1 year – 1 drop 5 times a day (single dose of 1000 IU daily dose of 5000 IU) for 5 days;
children from 1 year to 3 years – 2 drops 3-4 times a day (single dose of 2000 IU daily dose of 6000 – 8000 IU) for 5 days;
children from 3 to 14 years – to 2 drops 4-5 times a day (single dose of 2000 IU daily dose of 8000 – 10000 IU) for 5 days.
Interferon alpha-2b (rectal suppository) (used in complex therapy):
newborn babies – premature with gestational age less than 34 weeks – daily dose of 450,000 IU (150,000 IU for 3 times a day every 8 hours) for 5 days, after an interval of 5 days, repeated the same pattern (indication);
newborns, including preterm with a gestational age over 34 weeks – daily dose of 300,000 IU (150,000 IU in 2 times a day 12 hours) within 5 days after a break of 5 days, repeated the same pattern (indication);
children aged 1 month to 3 years – daily dose of 300000 (for 150000 IU 2 times a day 12 hours) for 7 days, after a break of 5 days, repeated the same pattern (indication of rates may be increased to three) ;
children aged 3 years to 7 years – a daily dose of 1,000,000 IU (at 500000 IU 2 times a day 12 hours) for 7 days, after a break of 5 days, repeated the same pattern (indication of rates may be increased up to three);
children aged 7 to 18 years – a daily dose of 1000000 (to 500000 IU 2 times a day 12 hours) during – 10 days after a break of 5 days, repeated the same pattern (indication of rates may be increased to three ).
2.2. Symptomatic treatment.
3. Treatment of children with moderate forms of influenza caused by virus type A H1N1.
3.1. Arbidol – children older than 7 years, the daily dose of 300 mg (3 times per day to 100 mg) for 3 days.
or
Oseltamivir (Powder for suspension for oral administration or capsules) not later than two days from the time of symptoms:
children from 1 to 8 years – with a weight of less than 15 kg to 30 mg, 15 to 23 kg of 45 mg, 23 to 40 kg to 60 mg over 40 kg – 75 mg 2 times a day for 5 days ;
children over 12 years – 75 mg 2 times a day for 5 days. Increasing the dose of 150 mg per day does not lead to greater effect.
Interferon gamma in combination with interferon alfa 2b (liofilizat for solution for intranasal administration, the contents of the vial or ampoule is dissolved in 5 ml of water for injections):
Interferon gamma – used in complex therapy at the first signs of the disease to children from 0 to 18 years to 2 drops in each nasal passage, 5 times a day for 5-7 days;
Interferon alfa 2b – is used in complex therapy at the first signs of the disease:
infants and children under 1 year – 1 drop 5 times a day (single dose of 1000 IU daily dose of 5000 IU) for 5 days;
children from 1 year to 3 years – 2 drops 3-4 times a day (single dose of 2000 IU daily dose of 6000 – 8000 IU) for 5 days;
children from 3 to 14 years – to 2 drops 4-5 times a day (single dose of 2000 IU daily dose of 8000 – 10000 IU) for 5 days.
Interferon alpha-2b (rectal suppository) (used in complex therapy):
newborn babies – premature with gestational age less than 34 weeks – daily dose of 450000 IU (3 times a day 150000 IU every 8 hours) for 7 days
newborns, including preterm with a gestational age over 34 weeks – daily dose of 300,000 IU (150,000 IU in 2 times a day 12 hours) for 7 days;
children aged 1 month to 3 years – daily dose of 300000 (for 150000 IU 2 times a day 12 hours) within 10 days after a break of 5 days, repeated the same pattern (indication of rates may be increased to three) ;
children aged from 3 to 7 years – a daily dose of 1,000,000 IU (at 500000 IU 2 times a day 12 hours) for 7 days, after a break of 5 days, repeated the same pattern (indication of rates may be increased to three);
children aged 7 to 18 years – a daily dose of 1000000 (to 500000 IU 2 times a day 12 hours) during – 10 days after a break of 5 days, repeated the same pattern (indication of rates may be increased to three) .
3.2. Symptomatic treatment (antibacterial and antifungal, antipyretics, the funds used to treat allergic reactions, drugs used in the treatment of syndrome bronhospazmolitiki, tools that reduce the swelling of mucous respiratory solutions, electrolytes, acid balance correction tools, foodstuffs, vitamins) – by testimony.
4. Treatment of children with severe forms of influenza caused by virus type AH1N1.
4.1. Arbidol – children older than 7 years, the daily dose of 300 mg (3 times per day to 100 mg) for 3 days.
or
Oseltamivir (Powder for suspension for oral administration or capsules) not later than two days from the time of symptoms:
children from 1 to 8 years – with a weight of less than 15 kg to 30 mg, 15 to 23 kg of 45 mg, 23 to 40 kg to 60 mg over 40 kg – 75 mg 2 times a day for 5 days ;
children over 12 years – 75 mg 2 times a day for 5 days. Increasing the dose of 150 mg per day does not lead to greater effect.
Interferon gamma in combination with interferon alfa 2b (liofilizat for solution for intranasal administration, the contents of the vial or ampoule is dissolved in 5 ml of water for injections):
Interferon gamma – used in complex therapy at the first signs of the disease to children from 0 to 18 years to 2 drops in each nasal passage, 5 times a day for 5-7 days;
Interferon alfa 2b – is used in complex therapy at the first signs of the disease:
infants and children under 1 year – 1 drop 5 times a day (single dose of 1000 IU daily dose of 5000 IU) for 5 days;
children from 1 year to 3 years – 2 drops 3-4 times a day (single dose of 2000 IU daily dose of 6000 – 8000 IU) for 5 days;
children from 3 to 14 years – to 2 drops 4-5 times a day (single dose of 2000 IU daily dose of 8000 – 10000 IU) for 5 days.
Interferon alpha-2b (rectal suppository) (used in complex therapy):
newborn babies – premature with gestational age less than 34 weeks – daily dose of 450000 IU (3 times per day at 150000 IU every 8 hours) within 10 days, followed by maintenance treatment: daily dose of 450,000 IU (150,000 IU for 3 times a day) on 2 times a week for 3 weeks;
newborns, including preterm with a gestational age over 34 weeks – daily dose of 300,000 IU (150,000 IU in 2 times a day 12 hours) within 10 days, followed by maintenance treatment: daily dose of 300,000 IU (150,000 IU in 2 times a day) for 2 times a week for 3 weeks;
children aged 1 month to 3 years – daily dose of 1000000 (to 500000 IU 2 times a day 12 hours) for 7 days, after a break of 5 days, repeated the same pattern (number of courses up to two can be increased if indicated) ;
children aged from 3 years to 7 years – a daily dose of 1,000,000 IU (at 500000 IU 2 times a day 12 hours) within 10 days after a break of 5 days, repeated the same pattern (number of courses up to three can be increased indication);
children aged 7 to 18 years – a daily dose of 1000000 (to 500000 IU 2 times a day 12 hours) during – 10 days, followed by maintenance treatment: daily dose of 1,000,000 IU (at 500000 IU 2 times a day) for 2 times a week for 3 weeks;
Children from 3 years to 18 years with severe forms of influenza with interferon alfa-2b can be used in conjunction with arbidol:
Interferon alpha-2b – daily dose of 500000 IU (for 1 suppository 2 times a day within 12 hours for 5 – days;
Arbidol – on 0,05 g 3 times a day for 5 days.
Then apply only Interferon alpha-2b on 500000ME 2 times a day for 5 days, if necessary, the number of courses may be increased to three, the intervals between courses of 5 days.
4.2. Symptomatic treatment (antibacterial and antifungal, antipyretics, the funds used to treat allergic reactions, drugs used in the treatment of syndrome bronhospazmolitiki, tools that reduce the swelling of mucous respiratory solutions, electrolytes, acid balance correction tools, foodstuffs, vitamins) – by testimony.
















































